Modification of adriamycin-induced cytotoxicity by recombinant human interferon-gamma and/or verapamil in human stomach cancer cells.
Recombinant human-interferon-gamma (rH-IFN-gamma) and verapamil (VRP), either alone or in combination, were evaluated in MTT assay for their modification effects on adriamycin-induced cytotoxicity against MKN-45, human stomach adenocarcinoma cells. VRP as a single agent did not inhibit the survival...
Main Authors: | Hong, W. S., Kim, C. M., Lee, C. T., Lee, J. O., Kang, T. W. |
---|---|
Format: | Online |
Language: | English |
Published: |
Korean Academy of Medical Sciences
1992
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3053775/ |
Similar Items
-
Chemosensitization to adriamycin by cyclosporin A and verapamil in human retinoblastoma cell lines.
by: Lee, T. W., et al.
Published: (1993) -
Inherent adriamycin resistance in a murine tumour line: circumvention with verapamil and norverapamil.
by: Merry, S., et al.
Published: (1989) -
Resistance of human glioma to adriamycin in vitro: the role of membrane transport and its circumvention with verapamil.
by: Merry, S., et al.
Published: (1986) -
Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16.
by: Smith, M. A., et al.
Published: (1988) -
Cytotoxicity of adriamycin to tumour cells in vivo and in vitro.
by: Martin, W. M., et al.
Published: (1980)